1,746
Views
41
CrossRef citations to date
0
Altmetric
Clinical Studies

Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer

, , , , , , , , , , , & show all
Pages 1289-1295 | Received 03 Mar 2015, Accepted 03 Jul 2015, Published online: 12 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Chengbao Feng, Jingjing Wang, Xue Yang, Xuefang Zang, Haikun Zhou, Erying Zhang, Haifei Li, Bo Liu, Shumin Chen, Ying Wang, Peng Wang, Lixue Gao & Jinyan Liu. (2020) Construction and Characterization of KRAS Immune Lipid Magnetic Balls for Colorectal Cancer Circulating Tumor Cells. Cancer Management and Research 12, pages 10067-10075.
Read now
Yuxin Cheng, Ting Wang, Xin Lv, Rutian Li, Ling Yuan, Jie Shen, Yan Li, Tingting Yan, Baorui Liu & Lifeng Wang. (2020) Detection of PD-L1 Expression and Its Clinical Significance in Circulating Tumor Cells from Patients with Non-Small-Cell Lung Cancer. Cancer Management and Research 12, pages 2069-2078.
Read now
Claudia Burz, Andreea Rosca, Vlad-Vasile Pop, Rares Buiga, Cornel Aldea, Gabriel Samasca, Ciprian Silaghi, Daniel Sur, Iulia Lupan & Andreea Pricopie. (2019) Liquid biopsy challenge and hope in colorectal cancer. Expert Review of Molecular Diagnostics 19:4, pages 341-348.
Read now
Wenjie He, Wenhui Li, Bo Jiang, Li Chang, Congguo Jin, Changlin Tu & Yunfen Li. (2016) Correlation between epidermal growth factor receptor tyrosine kinase inhibitor efficacy and circulating tumor cell levels in patients with advanced non-small cell lung cancer. OncoTargets and Therapy 9, pages 7515-7520.
Read now
Elaine Maggi, Nicole E Patterson & Cristina Montagna. (2016) Technological advances in precision medicine and drug development. Expert Review of Precision Medicine and Drug Development 1:3, pages 331-343.
Read now

Articles from other publishers (36)

Milena Shizue Tariki, Caroline Correia Ghensev Barberan, Jacqueline Aparecida Torres, Anna Paula Carreta Ruano, Daniela de Jesus Ferreira Costa, Alexcia Camila Braun, Vanessa da Silva Alves, Stenio de Cássio Zequi, Walter Henriques da Costa, André P. Fay, Giovana Torrezan, Dirce M. Carraro & Ludmilla T. Domingos Chinen. (2024) Circulating tumor cells as a predictor and prognostic tool for metastatic clear cell renal carcinoma: An immunocytochemistry and genomic analysis. Pathology - Research and Practice 253, pages 154918.
Crossref
Arnaud Martel, Baharia Mograbi, Barnabe Romeo, Lauris Gastaud, Salome Lalvee, Katia Zahaf, Julien Fayada, Sacha Nahon-Esteve, Christelle Bonnetaud, Myriam Salah, Virginie Tanga, Stéphanie Baillif, Corine Bertolotto, Sandra Lassalle & Paul Hofman. (2023) Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice. International Journal of Molecular Sciences 24:13, pages 11075.
Crossref
Sheefa Mirza, Kinjal Bhadresha, Muhammed Jameel Mughal, Michelle McCabe, Reza Shahbazi, Paul Ruff & Clement Penny. (2023) Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?. Frontiers in Oncology 12.
Crossref
Aleksandra Bożyk & Marcin Nicoś. (2022) The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer. Life 12:10, pages 1640.
Crossref
Pietro Andrei, Paolo Battuello, Gaia Grasso, Emanuele Rovera, Nicolò Tesio & Alberto Bardelli. (2022) Integrated approaches for precision oncology in colorectal cancer: The more you know, the better. Seminars in Cancer Biology 84, pages 199-213.
Crossref
Alka Yadav, Ashok Kumar & Mohammad Haris Siddiqui. (2021) Detection of circulating tumour cells in colorectal cancer: Emerging techniques and clinical implications. World Journal of Clinical Oncology 12:12, pages 1169-1181.
Crossref
Danfeng Lin, Lesang Shen, Meng Luo, Kun Zhang, Jinfan Li, Qi Yang, Fangfang Zhu, Dan Zhou, Shu Zheng, Yiding Chen & Jiaojiao Zhou. (2021) Circulating tumor cells: biology and clinical significance. Signal Transduction and Targeted Therapy 6:1.
Crossref
Alexcia C. Braun, Fernando A. B. Campos, Emne A. Abdallah, Anna P. C. Ruano, Tiago da S. Medina, Milena S. Tariki, Fabio F. E. Pinto, Celso A. L. de Mello & Ludmilla T. D. Chinen. (2021) Circulating Tumor Cells in Desmoid Tumors: New Perspectives. Frontiers in Oncology 11.
Crossref
Bianca C. T. Flores, Margareta P. Correia, José G. Rodríguez, Rui Henrique & Carmen Jerónimo. (2021) Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer. Cancers 13:16, pages 4209.
Crossref
Pamela Pinzani, Valeria D’Argenio, Marzia Del Re, Cristina Pellegrini, Federico Cucchiara, Francesca Salvianti & Silvia Galbiati. (2021) Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors. Clinical Chemistry and Laboratory Medicine (CCLM) 59:7, pages 1181-1200.
Crossref
Reyhaneh Moradi-Marjaneh, Fereshteh Asgharzadeh, Elnaz Khordad & Mahdi Moradi Marjaneh. (2021) The Clinical Impact of Quantitative Cell-free DNA, KRAS, and BRAF Mutations on Response to Anti-EGFR Treatment in Patients with Metastatic Colorectal Cancer. Current Pharmaceutical Design 27:7, pages 942-952.
Crossref
Virgílio Souza e Silva, Emne Ali Abdallah, Angelo Borsarelli Carvalho de Brito, Alexcia Camila Braun, Milena Shizue Tariki, Celso Abdon Lopes de Mello, Vinicius Fernando Calsavara, Rachel Riechelmann & Ludmilla Thomé Domingos Chinen. (2021) Baseline and Kinetic Circulating Tumor Cell Counts Are Prognostic Factors in a Prospective Study of Metastatic Colorectal Cancer. Diagnostics 11:3, pages 502.
Crossref
Wei Gao, Yigui Chen, Jianwei Yang, Changhua Zhuo, Sha Huang, Hui Zhang & Yi Shi. (2021) Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer. Frontiers in Genetics 12.
Crossref
Takahiro Okabe, Shinsaku Togo, Yuichi Fujimoto, Junko Watanabe, Issei Sumiyoshi, Akira Orimo & Kazuhisa Takahashi. (2020) Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy. Cancers 12:12, pages 3588.
Crossref
Hye Lee, Dae Hwang & Hye Han. (2020) Histology and its prognostic effect on KRAS‑mutated colorectal carcinomas in Korea. Oncology Letters.
Crossref
Shana O Kelley & Klaus Pantel. (2020) A New Era in Liquid Biopsy: From Genotype to Phenotype. Clinical Chemistry 66:1, pages 89-96.
Crossref
Alina Hasanain & Christopher L. Wolfgang. 2020. Translational Pancreatic Cancer Research. Translational Pancreatic Cancer Research 129 143 .
Leila Jahangiri & Tara Hurst. (2019) Assessing the Concordance of Genomic Alterations between Circulating-Free DNA and Tumour Tissue in Cancer Patients. Cancers 11:12, pages 1938.
Crossref
Emne A. Abdallah, Alexcia C. Braun, Bianca C.T.C.P. Flores, Laís Senda, Ana Cláudia Urvanegia, Vinicius Calsavara, Victor Hugo Fonseca de Jesus, Maria Fernanda Arruda Almeida, Maria Dirlei Begnami, Felipe J.F. Coimbra, Wilson Luiz da CostaJrJr, Diana Noronha Nunes, Emmanuel Dias-Neto & Ludmilla T. Domingos Chinen. (2019) The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer. The Oncologist 24:9, pages e854-e863.
Crossref
Yujie Zhao, Wenjie Ma, Shanzi Zou, Biao Chen, Hong Cheng, Xiaoxiao He & Kemin Wang. (2019) Terminal deoxynucleotidyl transferase-initiated molecule beacons arrayed aptamer probe for sensitive detection of metastatic colorectal cancer cells. Talanta 202, pages 152-158.
Crossref
Mônica Taiane de Macêdo Diaz, Emne Ali Abdallah, Milena Shizue Tariki, Alexcia Camila Braun, Aldo Lourenço Abbade Dettino, Ulisses Ribaldo Nicolau, Vanessa da Silva Alves & Ludmilla Thomé Domingos Chinen. (2018) Circulating tumor cells as marker of poor prognosis in metastatic lung cancer: a pilot study. Applied Cancer Research 38:1.
Crossref
Mayte Delgado-Ureña, Francisco G. Ortega, Diego de Miguel-Pérez, Alba Rodriguez-Martínez, Jose L. García-Puche, Hugh Ilyine, Jose A. Lorente, Jose Exposito-Hernandez, M. Carmen Garrido-Navas, Miguel Delgado-Ramirez & M. José Serrano. (2018) Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients. Journal of Translational Medicine 16:1.
Crossref
Yun Deng, Hui Zhang & Zhen Zhang. (2018) What Is the Future of Circulating Tumor Cells in Colorectal Cancer?. Current Colorectal Cancer Reports 14:6, pages 207-216.
Crossref
Chiara Molinari, Giorgia Marisi, Alessandro Passardi, Laura Matteucci, Giulia De Maio & Paola Ulivi. (2018) Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?. International Journal of Molecular Sciences 19:12, pages 3733.
Crossref
Lucile Broncy, Basma Ben Njima, Arnaud Méjean, Christophe Béroud, Khaled Ben Romdhane, Marius Ilie, Veronique Hofman, Jane Muret, Paul Hofman, Habiba Chaabouni Bouhamed & Patrizia Paterlini-Bréchot. (2018) Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma. Oncotarget 9:28, pages 20058-20074.
Crossref
Yuurin Kondo, Kazuhiko Hayashi, Kazuyuki Kawakami, Yukari Miwa, Hiroshi Hayashi & Masakazu Yamamoto. (2017) KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer. BMC Cancer 17:1.
Crossref
Yong Liu, Stefano Meucci, Liming Sheng & Ulrich Keilholz. (2017) Meta-analysis of the mutational status of circulation tumor cells and paired primary tumor tissues from colorectal cancer patients. Oncotarget 8:44, pages 77928-77941.
Crossref
Alexios Matikas, Alexandra Voutsina, Eleni Lagoudaki, Dora Hatzidaki, Maria Trypaki, Giannis Stoupis, Maria Tzardi, Dimitrios Mavroudis & Vasilios Georgoulias. (2017) Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer. Translational Oncology 10:4, pages 693-698.
Crossref
Matthew W. Rosenbaum, Christy E. Cauley, Birte Kulemann, Andrew S. Liss, Carlos Fernandez-del Castillo, Andrew L. Warshaw, Keith D. Lillemoe, Sarah P. Thayer & Martha B. Pitman. (2017) Cytologic characteristics of circulating epithelioid cells in pancreatic disease. Cancer Cytopathology 125:5, pages 332-340.
Crossref
Sophie Laget, Lucile Broncy, Katia Hormigos, Dalia M. Dhingra, Fatima BenMohamed, Thierry Capiod, Magne Osteras, Laurent Farinelli, Stephen Jackson & Patrizia Paterlini-Bréchot. (2017) Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion. PLOS ONE 12:1, pages e0169427.
Crossref
Ludmilla Thomé Domingos Chinen, Emne Ali Abdallah, Alexcia Camila Braun, Bianca de Cássia Troncarelli de Cam Flores, Marcelo Corassa, Solange Moraes Sanches & Marcello Ferretti Fanelli. 2017. Isolation and Molecular Characterization of Circulating Tumor Cells. Isolation and Molecular Characterization of Circulating Tumor Cells 1 41 .
Evelyn Kidess-Sigal, Haiyan E. Liu, Melanie M. Triboulet, James Che, Vishnu C. Ramani, Brendan C. Visser, George A. Poultsides, Teri A. Longacre, Andre Marziali, Valentina Vysotskaia, Matthew Wiggin, Kyra Heirich, Violet Hanft, Ulrich Keilholz, Ingeborg Tinhofer, Jeffrey A. Norton, Mark Lee, Elodie Sollier-Christen & Stefanie S. Jeffrey. (2016) Enumeration and targeted analysis of KRAS , BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer . Oncotarget 7:51, pages 85349-85364.
Crossref
Manjima Dhar, Edward Pao, Corinne Renier, Derek E. Go, James Che, Rosita Montoya, Rachel Conrad, Melissa Matsumoto, Kyra Heirich, Melanie Triboulet, Jianyu Rao, Stefanie S. Jeffrey, Edward B. Garon, Jonathan Goldman, Nagesh P. Rao, Rajan Kulkarni, Elodie Sollier-Christen & Dino Di Carlo. (2016) Label-free enumeration, collection and downstream cytological and cytogenetic analysis of circulating tumor cells. Scientific Reports 6:1.
Crossref
Jérôme Alexandre Denis, Alexia Patroni, Erell Guillerm, Dominique Pépin, Naoual Benali-Furet, Janine Wechsler, Gilles Manceau, Maguy Bernard, Florence Coulet, Annette K. Larsen, Mehdi Karoui & Jean-Marc Lacorte. (2016) Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery . Molecular Oncology 10:8, pages 1221-1231.
Crossref
Carlyn Rose C. Tan, Lanlan Zhou & Wafik S. El-Deiry. (2016) Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons. Current Colorectal Cancer Reports 12:3, pages 151-161.
Crossref
Andrea Ravelli, James M. Reuben, Francesco Lanza, Simone Anfossi, Maria Rosa Cappelletti, Laura Zanotti, Angela Gobbi, Chiara Senti, Paola Brambilla, Manuela Milani, Daniele Spada, Paolo Pedrazzoli, Massimo Martino, Alberto Bottini & Daniele Generali. (2015) Breast cancer circulating biomarkers: advantages, drawbacks, and new insights. Tumor Biology 36:9, pages 6653-6665.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.